Navigation Links
Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia

Recent research conducted in Germany indicates that bronchiolo–alveolar carcinoma frequently shows a sonographic pattern of ‘pneumonia’//.

The acoustic–physical conditions of the thorax produces the most serious limitations for the sonographic diagnosis of pulmonary diseases.

Sonography of pleural-based lesions has been established as a method complementary to conventional X-ray examination. The sonographic pattern of bacterial pneumonia is predominantly well known and characterized by an air bronchogram, a marked vascularity on color Doppler sonography, and a high-impedance arterial flow pattern on Doppler spectral analysis.

Bronchiolo–alveolar carcinoma (BAC) is defined as a special subtype of adenocarcinoma. Histologically it shows wallpaper like growth within the alveoli, confirmed to the topographical structures of the lung tissue.

The authors set out to describe the sonographic patterns of this tumor entity in seven consecutive patients with peripheral BAC on X-ray examination. Their findings appear in the October issue of the European Journal of Ultrasound. The analysis of data from this study demonstrates a marked vascularity or a vascular tree like pattern in all patients with BAC investigated, which are known to be characteristic for pneumonic or obstructive pulmonary lesions. The arterial spectral analysis of the patients predominantly showed a high-impedance flow in nearly all cases investigated. This flow pattern is also described to be characteristic for pneumonic or obstructive pulmonary lesions and is a well-known flow pattern of pulmonary arteries.

The authors conclude that BAC predominantly shows a pattern of ‘pneumonia’ as demonstrated by conventional B-mode sonography as well as color Doppler sonogrphy.
'"/>




Page: 1

Related medicine news :

1. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
2. Differentiated Thyroid Carcinoma Can Widely Infiltrate The Larynx
3. Probable Biomarkers for Squamous Cell Carcinoma
4. New Biotech Drugs to Aid in Renal Cell Carcinoma Treatment
5. Experimental treatment for Ebola Virus Shows promising results in mice
6. New Prostate Cancer Vaccine Shows Promise
7. Ebola Treatment Shows Promise
8. New Drug Shows Significant Improvement In HIV-related Heart Condition
9. Greek Study Shows Living In The Hills May Be Healthier
10. Research Shows Carbon Monoxide Prevents Inflammations
11. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... NJ (PRWEB) , ... December 02, 2016 , ... Sourced ... Water has some unique properties including its unmatched natural purity of just 6 ppm ... clean and crisp. , Nothing Water has been available in several ShopRite and FoodTown ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health Solutions, Inc., the ... million in an initial round of funding. The round was led by experienced ... can receive far better care through the application of the best technologies from ...
(Date:12/2/2016)... FL (PRWEB) , ... December 02, 2016 , ... ‘Tis ... are winners of $1,000 each from the National Family Partnership and the Drug Enforcement ... families who decorated their homes and the 10 winning schools who decorated their campuses ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... Deloitte Wisconsin 75, an annual ranking and recognition of the largest closely held ... list, having ranked from 2008-2016. In addition, Standard Process was awarded the Talent ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... tech functions and stylish design wanted by today’s consumers at an affordable price, ... Darin Philip says the new watch is “a game changer” when it comes ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 Orthopedic Implants (Including Spinal Implants, ... to Gain a Significant Market Share Owing to a Large ... ... According to a new report by Persistence ... Packaging: Clamshell Product Type Segment Projected to Witness a Significantly ...
(Date:12/2/2016)... , Dec. 2, 2016   CytoSorbents Corporation ... commercializing its European Union approved CytoSorb ® cytokine ... surgery patients worldwide, announced that Dr. Phillip Chan ... 9th Annual LD Micro Main Event investor conference ... at the Luxe Sunset Boulevard Hotel in ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite ended the trading ... edged 0.36% higher, to finish at 19,191.93; and the S&P ... as six out of nine sectors ended the day in ... Services equities: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Inc. (NASDAQ: INCR ), and La Quinta Holdings ...
Breaking Medicine Technology: